These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018). Sohng C, Sim HB, Kim JY, Lim Y, Han MH, Lee H, Ahn BC, Huh S, Lee SJ. Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454 [Abstract] [Full Text] [Related]
25. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique. Rutkowski P, Szydłowski K, Nowecki ZI, Sałamacha M, Goryń T, Mitręga-Korab B, Pieńkowski A, Dziewirski W, Zdzienicki M. World J Surg Oncol; 2015 Oct 13; 13():299. PubMed ID: 26462471 [Abstract] [Full Text] [Related]
26. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin. Melstrom LG, Taylor E, Kuk D, Frankel TL, Panageas K, Haydu L, Sabel MS, Thompson JF, Ariyan C, Coit DG, Brady MS. Ann Surg Oncol; 2014 Dec 13; 21(13):4324-9. PubMed ID: 24962937 [Abstract] [Full Text] [Related]
27. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma. Bello DM, Han G, Jackson L, Bulloch K, Ariyan S, Narayan D, Rothberg BG, Han D. Ann Surg Oncol; 2016 Dec 13; 23(Suppl 5):938-945. PubMed ID: 27527717 [Abstract] [Full Text] [Related]
29. The Role of Completion Lymph Node Dissection for Sentinel Lymph Node-Positive Melanoma. Hieken TJ, Kane JM, Wong SL. Ann Surg Oncol; 2019 Apr 13; 26(4):1028-1034. PubMed ID: 30284132 [Abstract] [Full Text] [Related]
30. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma. Page AJ, Carlson GW, Delman KA, Murray D, Hestley A, Cohen C. Am Surg; 2007 Jul 13; 73(7):674-8; discussion 678-9. PubMed ID: 17674939 [Abstract] [Full Text] [Related]
32. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma. Gyorki DE, Boyle JO, Ganly I, Morris L, Shaha AR, Singh B, Wong RJ, Shah JP, Busam K, Kraus D, Coit DG, Patel S. Eur J Surg Oncol; 2014 Mar 13; 40(3):305-10. PubMed ID: 24361245 [Abstract] [Full Text] [Related]
33. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Nowecki ZI, Rutkowski P, Michej W. Ann Surg Oncol; 2008 Aug 13; 15(8):2223-34. PubMed ID: 18506535 [Abstract] [Full Text] [Related]
34. Management of the positive sentinel lymph node in the post-MSLT-II era. Bredbeck BC, Mubarak E, Zubieta DG, Tesorero R, Holmes AR, Dossett LA, VanKoevering KK, Durham AB, Hughes TM. J Surg Oncol; 2020 Dec 13; 122(8):1778-1784. PubMed ID: 32893366 [Abstract] [Full Text] [Related]